63 related articles for article (PubMed ID: 35697228)
1. H3K27M-Altered Diffuse Midline Gliomas Among Adult Patients: A Systematic Review of Clinical Features and Survival Analysis.
Bin-Alamer O; Jimenez AE; Azad TD; Bettegowda C; Mukherjee D
World Neurosurg; 2022 Sep; 165():e251-e264. PubMed ID: 35697228
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
[TBL] [Abstract][Full Text] [Related]
3. Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma.
Gong X; Kuang S; Deng D; Wu J; Zhang L; Liu C
CNS Neurosci Ther; 2023 Dec; 29(12):3863-3875. PubMed ID: 37311690
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Indicators for H3K27M-Mutant Diffuse Midline Glioma: A Population-Based Retrospective Surveillance, Epidemiology, and End Results Database Analysis.
Adhikari S; Bhutada AS; Ladner L; Cuoco JA; Entwistle JJ; Marvin EA; Rogers CM
World Neurosurg; 2023 Oct; 178():e113-e121. PubMed ID: 37423332
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma.
Zang D; Dong Z; Liu Y; Chen Q
BMC Neurol; 2024 Feb; 24(1):74. PubMed ID: 38383423
[TBL] [Abstract][Full Text] [Related]
6. Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.
Mosaab A; El-Ayadi M; Khorshed EN; Amer N; Refaat A; El-Beltagy M; Hassan Z; Soror SH; Zaghloul MS; El-Naggar S
Sci Rep; 2020 May; 10(1):8368. PubMed ID: 32433577
[TBL] [Abstract][Full Text] [Related]
7. A H3K27M-targeted vaccine in adults with diffuse midline glioma.
Grassl N; Poschke I; Lindner K; Bunse L; Mildenberger I; Boschert T; Jähne K; Green EW; Hülsmeyer I; Jünger S; Kessler T; Suwala AK; Eisele P; Breckwoldt MO; Vajkoczy P; Grauer OM; Herrlinger U; Tonn JC; Denk M; Sahm F; Bendszus M; von Deimling A; Winkler F; Wick W; Platten M; Sahm K
Nat Med; 2023 Oct; 29(10):2586-2592. PubMed ID: 37735561
[TBL] [Abstract][Full Text] [Related]
8. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways.
Pun M; Pratt D; Nano PR; Joshi PK; Jiang L; Englinger B; Rao A; Cieslik M; Chinnaiyan AM; Aldape K; Pfister S; Filbin MG; Bhaduri A; Venneti S
Acta Neuropathol Commun; 2023 Feb; 11(1):25. PubMed ID: 36759899
[TBL] [Abstract][Full Text] [Related]
9. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Venneti S; Kawakibi AR; Ji S; Waszak SM; Sweha SR; Mota M; Pun M; Deogharkar A; Chung C; Tarapore RS; Ramage S; Chi A; Wen PY; Arrillaga-Romany I; Batchelor TT; Butowski NA; Sumrall A; Shonka N; Harrison RA; de Groot J; Mehta M; Hall MD; Daghistani D; Cloughesy TF; Ellingson BM; Beccaria K; Varlet P; Kim MM; Umemura Y; Garton H; Franson A; Schwartz J; Jain R; Kachman M; Baum H; Burant CF; Mottl SL; Cartaxo RT; John V; Messinger D; Qin T; Peterson E; Sajjakulnukit P; Ravi K; Waugh A; Walling D; Ding Y; Xia Z; Schwendeman A; Hawes D; Yang F; Judkins AR; Wahl D; Lyssiotis CA; de la Nava D; Alonso MM; Eze A; Spitzer J; Schmidt SV; Duchatel RJ; Dun MD; Cain JE; Jiang L; Stopka SA; Baquer G; Regan MS; Filbin MG; Agar NYR; Zhao L; Kumar-Sinha C; Mody R; Chinnaiyan A; Kurokawa R; Pratt D; Yadav VN; Grill J; Kline C; Mueller S; Resnick A; Nazarian J; Allen JE; Odia Y; Gardner SL; Koschmann C
Cancer Discov; 2023 Nov; 13(11):2370-2393. PubMed ID: 37584601
[TBL] [Abstract][Full Text] [Related]
10. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract][Full Text] [Related]
11. H3K27M-mutant glioma in thoracic spinal cord and conus medullaris with pilocytic astrocytoma morphology: case report and review of the literature.
Palpan Flores A; Rodríguez Domínguez V; Esteban Rodriguez I; Román de Aragón M; Zamarrón Pérez Á
Br J Neurosurg; 2021 Oct; ():1-7. PubMed ID: 34615413
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma.
Khan AB; Dang HQ; Gopakumar S; Lazaro T; Gadgil N; Baxter P; Malbari F; Aldave G
J Neurooncol; 2023 Nov; 165(2):353-360. PubMed ID: 37945818
[TBL] [Abstract][Full Text] [Related]
13. Demonstrated efficacy and mechanisms of sensitivity of ONC201: H3K27M-mutant diffuse midline glioma in the spotlight.
Arrillaga-Romany I; Miller JJ
Neuro Oncol; 2024 Jun; 26(6):991-992. PubMed ID: 38588460
[No Abstract] [Full Text] [Related]
14. Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.
Watanabe G; Wong JM; Estes B; Khan MF; Ogasawara C; Umana GE; Martin AR; Bloch O; Palmisciano P
J Neurooncol; 2024 Feb; 166(3):379-394. PubMed ID: 38342826
[TBL] [Abstract][Full Text] [Related]
15. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.
Filbin MG; Tirosh I; Hovestadt V; Shaw ML; Escalante LE; Mathewson ND; Neftel C; Frank N; Pelton K; Hebert CM; Haberler C; Yizhak K; Gojo J; Egervari K; Mount C; van Galen P; Bonal DM; Nguyen QD; Beck A; Sinai C; Czech T; Dorfer C; Goumnerova L; Lavarino C; Carcaboso AM; Mora J; Mylvaganam R; Luo CC; Peyrl A; Popović M; Azizi A; Batchelor TT; Frosch MP; Martinez-Lage M; Kieran MW; Bandopadhayay P; Beroukhim R; Fritsch G; Getz G; Rozenblatt-Rosen O; Wucherpfennig KW; Louis DN; Monje M; Slavc I; Ligon KL; Golub TR; Regev A; Bernstein BE; Suvà ML
Science; 2018 Apr; 360(6386):331-335. PubMed ID: 29674595
[TBL] [Abstract][Full Text] [Related]
16. Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review.
Roux A; Zanello M; Antonia Simboli G; Varlet P; Tauziede-Espariat A; Beccaria K; Blauwblomme T; Puget S; Oppenheim C; Dangouloff-Ros V; Boddaert N; Dhermain F; Dufour C; Grill J; Chretien F; Pallud J
Oncology; 2023; 101(4):240-251. PubMed ID: 36603564
[TBL] [Abstract][Full Text] [Related]
17. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
Roberts HJ; Ji S; Picca A; Sanson M; Garcia M; Snuderl M; Schüller U; Picart T; Ducray F; Green AL; Nakano Y; Sturm D; Abdullaev Z; Aldape K; Dang D; Kumar-Sinha C; Wu YM; Robinson D; Vo JN; Chinnaiyan AM; Cartaxo R; Upadhyaya SA; Mody R; Chiang J; Baker S; Solomon D; Venneti S; Pratt D; Waszak SM; Koschmann C
Acta Neuropathol; 2023 Dec; 146(6):849-852. PubMed ID: 37851269
[No Abstract] [Full Text] [Related]
18. Does H3K27M Mutation Impact Survival Outcome of High-Grade Spinal Cord Astrocytoma?
Zhang F; Cheng L; Ding Z; Wang S; Zhao X; Zhao Z; Liang C; Wu K; Zhang D; Wang Y; Fan T
Neurospine; 2023 Dec; 20(4):1480-1489. PubMed ID: 38171314
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors analysis of diffuse midline glioma.
Jiang J; Li WB; Xiao SW
J Neurooncol; 2024 Apr; 167(2):285-292. PubMed ID: 38381257
[TBL] [Abstract][Full Text] [Related]
20. STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma.
Anderson JB; Bouchal SM; Zhang L; Daniels DJ
Oncotarget; 2023 Oct; 14():858-859. PubMed ID: 37791912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
